Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-26.43
Near historical average
Percentile
P33
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-28.57
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -26.43 | -482.1% |
| 2024 | -4.54 | -198.8% |
| 2023 | -1.52 | +53.0% |
| 2022 | -3.24 | +62.1% |
| 2021 | -8.54 | +75.5% |
| 2020 | -34.87 | +71.1% |
| 2019 | -120.87 | - |